MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2026.1844938

Медицинская библиотека · Frontiers in oncology · 2026

Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.

Hou Hailing, Zhang Li, Li Chen, Liu Miao

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Locally advanced cervical cancer (LACC) remains a major global health burden, and current imaging-based assessment after standard concurrent chemoradiotherapy (CCRT) is limited by delayed detection of treatment failure and poor sensitivity for microscopic residual disease. Circulating human papillomavirus DNA (HPV ctDNA) represents a tumor-specific biomarker with potential for real-time treatment monitoring. This prospective cohort study aims to evaluate whether dynamic monitoring of plasma HPV ctDNA can predict treatment response and prognosis in patients with LACC receiving CCRT.

METHODS/

DESIGN

This single-center, observational cohort study will enroll 57 patients with histologically confirmed LACC (FIGO 2018 stage IB2-IVA) and baseline high-risk HPV infection. All patients will receive standard CCRT including external beam radiotherapy (45-50.4 Gy), concurrent weekly cisplatin (40 mg/m²), and intracavitary brachytherapy. Peripheral blood samples (10 mL) will be collected at five predefined time points: baseline (T0), mid-treatment (T1), end of CCRT (T2), 3 months post-CCRT (T3), and every 6 months thereafter for 24 months. Plasma HPV ctDNA will be quantified using droplet digital PCR targeting HPV16/18 E6/E7 genes. The primary endpoint is progression-free survival (PFS), comparing patients with detectable versus undetectable ctDNA at 3 months post-CCRT.

CONCLUSION

This study will provide prospective evidence for HPV ctDNA as a minimally invasive biomarker for treatment monitoring and prognostic stratification in LACC, potentially informing future risk-adapted therapeutic strategies.

Для цитирования: Hou Hailing, Zhang Li, Li Chen, Liu Miao. Plasma HPV ctDNA as a dynamic biomarker for treatment response and prognosis in locally advanced cervical cancer: protocol for a prospective cohort study.. Frontiers in oncology. 2026. DOI: 10.3389/fonc.2026.1844938.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.